FDA. (2015)FDA approves first-of-its-kind

product for the treatment of melanoma.

Cohen M., Elkabets M., Perlmutter M., et al.

(2010). Sialylation of 3methylcholanthreneinduced fibrosarcoma determines antitumor

immune responses during immunoediting. J

Immunol, 185:5869–5878.

Ohtsuji M., Lin Q., Okazaki H., et al. (2018).

Anti-CD11b antibody treatment suppresses

the osteoclast generation, inflammatory cell

infiltration, and autoantibody production in

arthritis-prone FcγRIIB-deficient mice.Arthritis

Research & Therapy, 20(25):1-11.

Stenström M., Sköld M., Ericsson A., et al.

(2004). Surface receptors identify mouse NK1.1+

T cell subsets distinguished by function and T

cell receptor type. Euro Journal Immunology,

:56-65.

Holst K., Guseva D., Schindler S., et al. (2015).

The serotonin receptor 5-HT7R regulates the

morphology and migratory properties of dendritic

cells. Journal of Cell Science, 128:2866-2880.

Myers R., Greiner S., Harvey M., et al. (2005).

Oncolytic activities of approved mumps and

measles vaccines for therapy of ovarian cancer.

Cancer Gene Therapy, 12:593-599.

Ammayappan A., Russell S.J., Federspiel

M.J. (2016). Recombinant mumps virus as a

cancer therapeutic agent. Molecular TherapyOncolytics, 3:1-10.

Zhang L.F., Tan D.Q.C., Jeyasekharan A.D.,

et al. (2014). Combination of vaccine-strain

measles and mumps virus synergistically kills

a wide range of human hematological cancer

cells: Special focus on acute myeloid leukemia.

Cancer Letters, 1-9.